Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of ixekizumab treatment on skin-related personal relationship difficulties in moderate-to-severe psoriasis patients: 12-week results from two Phase 3 trials.
Guenther L, Warren RB, Cather JC, Sofen H, Poulin Y, Lebwohl M, Terui T, Potts Bleakman A, Zhu B, Burge R, Reich K, van de Kerkhof P. Guenther L, et al. Among authors: potts bleakman a. J Eur Acad Dermatol Venereol. 2017 Nov;31(11):1867-1875. doi: 10.1111/jdv.14377. Epub 2017 Sep 4. J Eur Acad Dermatol Venereol. 2017. PMID: 28573743 Clinical Trial.
Impact of ixekizumab on facial psoriasis and related quality of life measures in moderate-to-severe psoriasis patients: 12-week results from two phase III trials.
Paul C, Guenther L, Torii H, Sofen H, Burge R, Lin CY, Potts Bleakman A, Mallbris L, Poulin Y. Paul C, et al. Among authors: potts bleakman a. J Eur Acad Dermatol Venereol. 2018 Jan;32(1):68-72. doi: 10.1111/jdv.14581. Epub 2017 Oct 6. J Eur Acad Dermatol Venereol. 2018. PMID: 28881462 Clinical Trial.
Patients' Perspectives on the Impact of Genital Psoriasis: A Qualitative Study.
Cather JC, Ryan C, Meeuwis K, Potts Bleakman AJ, Naegeli AN, Edson-Heredia E, Poon JL, Jones C, Wallace AN, Guenther L, Fretzin S. Cather JC, et al. Dermatol Ther (Heidelb). 2017 Dec;7(4):447-461. doi: 10.1007/s13555-017-0204-3. Epub 2017 Oct 26. Dermatol Ther (Heidelb). 2017. PMID: 29076000 Free PMC article.
Prevalence of genital psoriasis in patients with psoriasis.
Meeuwis KAP, Potts Bleakman A, van de Kerkhof PCM, Dutronc Y, Henneges C, Kornberg LJ, Menter A. Meeuwis KAP, et al. Among authors: potts bleakman a. J Dermatolog Treat. 2018 Dec;29(8):754-760. doi: 10.1080/09546634.2018.1453125. Epub 2018 Mar 28. J Dermatolog Treat. 2018. PMID: 29565190 Review.
Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis.
Ryan C, Menter A, Guenther L, Blauvelt A, Bissonnette R, Meeuwis K, Sullivan J, Cather JC, Yosipovitch G, Gottlieb AB, Merola JF, Callis Duffin K, Fretzin S, Osuntokun OO, Burge R, Naegeli AN, Yang FE, Lin CY, Todd K, Potts Bleakman A; IXORA-Q Study Group. Ryan C, et al. Among authors: potts bleakman a. Br J Dermatol. 2018 Oct;179(4):844-852. doi: 10.1111/bjd.16736. Epub 2018 Jul 22. Br J Dermatol. 2018. PMID: 29747232 Clinical Trial.
Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial.
Guenther L, Potts Bleakman A, Weisman J, Poulin Y, Spelman L, Burge R, Erickson J, Todd K, Bertram CC, Ryan C. Guenther L, et al. Among authors: potts bleakman a. Acta Derm Venereol. 2020 Jan 7;100(1):adv00006. doi: 10.2340/00015555-3353. Acta Derm Venereol. 2020. PMID: 31620802 Free PMC article. Clinical Trial.
16 results